Výsledky vyhledávání - "David A van de Vijver"

Akademický článek

Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.

Autor: Mattia C F Prosperi, Michal Rosen-Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, Peter Sloot, David A van de Vijver, Anne-Mieke Vandamme, Anders Sönnerborg, EuResist study group, Virolab study group

Publikováno v: PLoS ONE, Vol 5, Iss 10, p e13753 (2010)

BackgroundAlthough genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) imp

Externí odkaz: https://doaj.org/article/133459cb09394a9d94e80aa53ce3dc4f

Zobrazit plný text záznamu

Akademický článek

Pre-treatment HIV drug resistance testing cost-effectiveness

Autor: David AMC van de Vijver, Brooke E Nichols

Publikováno v: EClinicalMedicine, Vol 22, Iss , Pp - (2020)

Externí odkaz: https://doaj.org/article/62db3259c8634d06a476d029494eafad

Zobrazit plný text záznamu

Akademický článek

Feasibility of Four Interventions to Improve Treatment Adherence in Migrants Living with HIV in The Netherlands

Autor: Sabrina K. Been, David A.M.C. van de Vijver, Jannigje Smit, Nadine Bassant, Katalin Pogány, Sarah E. Stutterheim, Annelies Verbon

Publikováno v: Diagnostics, Vol 10, Iss 11, p 980 (2020)

We evaluated the feasibility and efficacy of four existing interventions to improve adherence to them in migrants living with HIV (MLWH): directly administered antiretroviral therapy (DAART), group medical appointments (GMA), early detection and trea

Externí odkaz: https://doaj.org/article/eb3272b466f84a038bb9e55fb0396247

Zobrazit plný text záznamu

Plný text ve formátu HTML

HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case report

Autor: Jeroen J.A. van Kampen, Hanh Thi Pham, Sunbin Yoo, Ronald J. Overmars, Cynthia Lungu, Rizwan Mahmud, Carolina A.M. Schurink, Sander van Boheemen, Rob A. Gruters, Pieter L.A. Fraaij, David M. Burger, Jolanda J.C. Voermans, Casper Rokx, David A.M.C. van de Vijver, Thibault Mesplède

Publikováno v: Journal of Global Antimicrobial Resistance, 31, 323-327
Journal of Global Antimicrobial Resistance, 31, pp. 323-327
Journal of Global Antimicrobial Resistance, 31, 323-327. Elsevier

Objectives: We report a case of incomplete HIV-1 suppression on a dolutegravir, lamivudine, and abacavir single-tablet regimen with the emergence of the H51Y and G118R integrase resistance mutations. Methods: Integrase sequencing was performed retros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfcb608bc879de4474d2563fde803088
http://hdl.handle.net/2066/286906

Zobrazit plný text záznamu